Cindy R. Tahl
2021
In 2021, Cindy R. Tahl earned a total compensation of $6.5M as General Counsel and Corporate Secretary at Fate Therapeutics, a 163% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $172,000 |
|---|---|
| Option Awards | $500,000 |
| Salary | $430,000 |
| Stock Awards | $5,375,416 |
| Total | $6,477,416 |
Tahl received $5.4M in stock awards, accounting for 83% of the total pay in 2021.
Tahl also received $172K in non-equity incentive plan, $500K in option awards and $430K in salary.
Rankings
In 2021, Cindy R. Tahl's compensation ranked 1,946th out of 12,397 executives tracked by ExecPay. In other words, Tahl earned more than 84.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,946 out of 12,397 | 84th |
Division Manufacturing | 735 out of 5,492 | 87th |
Major group Chemicals And Allied Products | 281 out of 2,367 | 88th |
Industry group Drugs | 240 out of 2,090 | 89th |
Industry Biological Products, Except Diagnostic Substances | 72 out of 452 | 84th |
Source: SEC filing on April 25, 2022.
Tahl's colleagues
We found five more compensation records of executives who worked with Cindy R. Tahl at Fate Therapeutics in 2021.
2021
J Wolchko
Fate Therapeutics
Chief Executive Officer
2021
Mark Plavsic
Fate Therapeutics
Chief Technology Officer
2021
Bahram Valamehr
Fate Therapeutics
Chief Research and Development Officer
2021
Yu-Waye Chu
Fate Therapeutics
Chief Medical Officer
2021
Edward Dulac
Fate Therapeutics